Literature DB >> 20121602

Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix.

Mary Kay Washington1, Laura H Tang, Jordan Berlin, Philip A Branton, Lawrence J Burgart, David K Carter, Carolyn C Compton, Patrick L Fitzgibbons, Wendy L Frankel, J Milburn Jessup, Sanjay Kakar, Bruce Minsky, Raouf E Nakhleh.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20121602     DOI： 10.5858/134.2.171

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN： 0003-9985            Impact factor:   5.534


× No keyword cloud information.
  4 in total

1.  NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas.

Authors:  Matthew H Kulke; Lowell B Anthony; David L Bushnell; Wouter W de Herder; Stanley J Goldsmith; David S Klimstra; Stephen J Marx; Janice L Pasieka; Rodney F Pommier; James C Yao; Robert T Jensen
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

Review 2.  [Surgical strategies for accidental detection of appendix carcinoids].

Authors:  H Dralle
Journal:  Chirurg       Date:  2011-07       Impact factor: 0.955

3.  Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters.

Authors:  Mee-Yon Cho; Jin Hee Sohn; So Young Jin; Hyunki Kim; Eun Sun Jung; Mi-Jung Kim; Kyoung-Mee Kim; Woo Ho Kim; Joon Mee Kim; Yun Kyung Kang; Joon Hyuk Choi; Dae Young Kang; Youn Wha Kim; Eun Hee Choi
Journal:  Korean J Pathol       Date:  2013-06-25

4.  Radical surgical treatment of neuroendocrine tumors of the appendix in children - a Polish multicenter study.

Authors:  Małgorzata Panek; Marek Szymczak; Maria Stepaniuk; Wojciech Górecki; Aleksandra Gawłowska-Marciniak; Przemysław Wolak; Dariusz Zbyrad; Marek Rybkiewicz; Kamila Chrobak; Ryszard Noparlik; Jerzy Niedzielski; Przemysław Janik; Jan Nowak; Witold Miaśkiewicz; Andrzej Kamiński; Wojciech Fischer; Bożena Dembowska-Bagińska; Piotr Kaliciński
Journal:  Arch Med Sci       Date:  2021-04-23       Impact factor: 3.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.